ARCH VIII - DENALI THERAPEUTICS INC. 13G

Company

Denali Therapeutics Inc.

Filed

February 2, 2018

Accession Number

0001072613-18-000078

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →